Novartis Investigative Site — Medford, Oregon

Novartis Investigative Site is a clinical research site located in Medford, Oregon, United States 97504.

Crixeo Clinical Trials Trust Score: 24/100 (FAILING). This profile has not yet been claimed by the site owner.

Novartis Investigative Site has participated in 31 clinical trials.

Therapeutic areas: Asthma, Chronic Obstructive Pulmonary Disease, COPD.

Sponsors: Novartis Pharmaceuticals, Novartis.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Medford

Browse all research sites in Oregon · View every site in Medford

• GSK Investigational Site
• Research Site
• Velocity Clinical Research Medford
• Asante Rogue Regional Medical Center
• Clinical Research Institute of Southern Oregon PC
• Providence Medford Medical Center
• Sunstone Medical Research
• Pfizer Investigational Site
• Rogue Valley Medical Center
• Velocity Clinical Research
• Duramed Investigational Site

Sponsor Feasibility Report

Trust Score: 24/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Novartis Investigative Site?

Novartis Investigative Site has a Crixeo Trust Score of 24/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Novartis Investigative Site conducted?

Novartis Investigative Site has 31 clinical trials on record. Their work covers Asthma, Chronic Obstructive Pulmonary Disease, COPD.

Is Novartis Investigative Site accredited by Crixeo Clinical Trials?

Novartis Investigative Site has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Novartis Investigative Site?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.